Cargando…
Ischemia/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation
Hepatic ischemia/reperfusion injury (IRI) is aggravated by steatosis and is a main risk factor in fatty liver transplantation. Adenosine receptors (ARs) are emerging as therapeutic targets in liver diseases. By using cellular and in vivo systems of hepatic steatosis and IRI, here we evaluated the ef...
Autores principales: | Alchera, Elisa, Chandrashekar, Bangalore R., Clemente, Nausicaa, Borroni, Ester, Boldorini, Renzo, Carini, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618984/ https://www.ncbi.nlm.nih.gov/pubmed/34831394 http://dx.doi.org/10.3390/cells10113171 |
Ejemplares similares
-
DUSP12 acts as a novel endogenous protective signal against hepatic ischemia–reperfusion damage by inhibiting ASK1 pathway
por: Boldorini, Renzo, et al.
Publicado: (2021) -
TRAF1 Exacerbates Myocardial Ischemia Reperfusion Injury via ASK1–JNK/p38 Signaling
por: Xu, Weipan, et al.
Publicado: (2019) -
Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype
por: Alchera, Elisa, et al.
Publicado: (2015) -
Hepatocellular SETDB1 Regulates Hepatic Ischemia-Reperfusion Injury through Targeting Lysine Methylation of ASK1 Signal
por: Xia, Kang, et al.
Publicado: (2023) -
miR-1 Exacerbates Cardiac Ischemia-Reperfusion Injury in Mouse Models
por: Pan, Zhenwei, et al.
Publicado: (2012)